Diabetes-associated cardiac autonomic neuropathy

Area of Science:

• Cardiology
• Endocrinology
• Diabetology

Background:

• Cardiac autonomic neuropathy (CAN) is a significant, underdiagnosed cardiovascular complication in patients with diabetes.
• The increasing prevalence of diabetes, particularly in aging populations, heightens the risk of CAN and its associated morbidity.
• Early detection and management of CAN are crucial for preventing adverse cardiovascular events.

Purpose of the Study:

• To highlight the critical role of Nurse Practitioners (NPs) in screening for Cardiac Autonomic Neuropathy (CAN).
• To emphasize the importance of NP-led screening in the context of rising diabetes incidence among older adults.
• To underscore the potential for NPs to mitigate diabetes-related cardiovascular complications through CAN management.

Main Methods:

• This study focuses on the clinical and epidemiological aspects of CAN in diabetic patients.
• It reviews the capabilities and responsibilities of NPs in cardiovascular risk assessment.
• The approach involves synthesizing current literature on diabetes, CAN, and the role of advanced practice nurses.

Main Results:

• Cardiac autonomic neuropathy (CAN) remains underdiagnosed, representing a substantial unmet clinical need.
• Nurse Practitioners (NPs) are well-positioned to implement systematic screening protocols for CAN.
• Proactive screening by NPs can lead to timely interventions, potentially reducing cardiovascular complications.

Conclusions:

• NPs play a pivotal role in the early detection and management of Cardiac Autonomic Neuropathy (CAN).
• Integrating CAN screening into routine NP practice is essential for managing cardiovascular risks in the growing diabetic population.
• Empowering NPs to screen for and manage CAN can significantly improve patient outcomes and prevent long-term complications.